Bibliographic Details
| Title: |
Long-term follow-up including extensive complement analysis of a pediatric C3 glomerulopathy cohort. |
| Authors: |
Michels, Marloes A. H. M., Wijnsma, Kioa L., Kurvers, Roel A. J., Westra, Dineke, Schreuder, Michiel F., van Wijk, Joanna A. E., Bouts, Antonia H. M., Gracchi, Valentina, Engels, Flore A. P. T., Keijzer-Veen, Mandy G., Dorresteijn, Eiske M., Volokhina, Elena B., van den Heuvel, Lambertus P. W. J., van de Kar, Nicole C. A. J. |
| Source: |
Pediatric Nephrology; Mar2022, Vol. 37 Issue 3, p601-612, 12p, 3 Charts, 2 Graphs |
| Subject Terms: |
PATIENT aftercare, GLOMERULAR filtration rate, CLINICAL pathology, BIOMARKERS, AUTOANTIBODIES, COMPLEMENT (Immunology), RESEARCH methodology, IMMUNOSUPPRESSION, GENES, GLOMERULONEPHRITIS, LONGITUDINAL method |
| Geographic Terms: |
NETHERLANDS |
| Abstract: |
Background: C3 glomerulopathy (C3G) is a rare kidney disorder characterized by predominant glomerular depositions of complement C3. C3G can be subdivided into dense deposit disease (DDD) and C3 glomerulonephritis (C3GN). This study describes the long-term follow-up with extensive complement analysis of 29 Dutch children with C3G. Methods: Twenty-nine C3G patients (19 DDD, 10 C3GN) diagnosed between 1992 and 2014 were included. Clinical and laboratory findings were collected at presentation and during follow-up. Specialized assays were used to detect rare variants in complement genes and measure complement-directed autoantibodies and biomarkers in blood. Results: DDD patients presented with lower estimated glomerular filtration rate (eGFR). C3 nephritic factors (C3NeFs) were detected in 20 patients and remained detectable over time despite immunosuppressive treatment. At presentation, low serum C3 levels were detected in 84% of all patients. During follow-up, in about 50% of patients, all of them C3NeF-positive, C3 levels remained low. Linear mixed model analysis showed that C3GN patients had higher soluble C5b-9 (sC5b-9) and lower properdin levels compared to DDD patients. With a median follow-up of 52 months, an overall benign outcome was observed with only six patients with eGFR below 90 ml/min/1.73 m2 at last follow-up. Conclusions: We extensively described clinical and laboratory findings including complement features of an exclusively pediatric C3G cohort. Outcome was relatively benign, persistent low C3 correlated with C3NeF presence, and C3GN was associated with higher sC5b-9 and lower properdin levels. Prospective studies are needed to further elucidate the pathogenic mechanisms underlying C3G and guide personalized medicine with complement therapeutics. [ABSTRACT FROM AUTHOR] |
|
Copyright of Pediatric Nephrology is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
|
Full text is not displayed to guests. |
Login for full access.
|
